Fusidic acid-induced leukopenia and thrombocytopenia

Yu-Min Liao1, Chang-Fang Chiu, Mao-Wang Ho

  • 1Division of Hematology/Oncology, Department of Internal Medicine, China Medical College Hospital, Taichung, Taiwan, ROC.

Insights

Fusidic acid can cause rare blood disorders like leukopenia and thrombocytopenia, particularly in Asian populations. Monitoring blood counts during long-term treatment is recommended to prevent adverse effects.

Area of Science:

  • Pharmacology
  • Hematology
  • Infectious Diseases

Background:

  • Fusidic acid is effective against Gram-positive bacteria, including MRSA.
  • Common side effects include gastrointestinal issues; hematological effects are rare.
  • Hematological adverse effects of fusidic acid have not been documented in Asian populations.

Purpose of the Study:

  • To report two cases of fusidic acid-induced leukopenia and thrombocytopenia in Asian patients.
  • To review the literature on fusidic acid-associated hematological adverse effects.
  • To speculate on the mechanism and recommend monitoring.

Main Methods:

  • Case report of two patients treated with fusidic acid.
  • Review of published literature on fusidic acid's hematological side effects.
  • Speculation on immune-mediated mechanisms.

Main Results:

  • Two cases of leukopenia and thrombocytopenia occurred after two weeks of fusidic acid treatment.
  • Hematological abnormalities resolved within 3-6 days after drug discontinuation.
  • Literature review confirmed rare but serious hematological side effects.

Conclusions:

  • Fusidic acid can induce leukopenia and thrombocytopenia, even in Asian populations.
  • An immune-mediated mechanism involving drug-dependent antibodies is suspected.
  • Periodic complete blood count monitoring is advised for patients on long-term fusidic acid therapy.

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Inhalation Anthrax01:25

Inhalation Anthrax

Anthrax is a zoonotic disease caused by Bacillus anthracis, a Gram-positive, spore-forming bacterium. It primarily affects herbivorous animals but can be transmitted to humans through skin contact, ingestion, or inhalation of spores.Cutaneous anthrax, the most common form, typically results from direct contact with bacterial spores through skin abrasions and is generally less severe. Gastrointestinal anthrax results from eating undercooked or contaminated meat. It affects the mouth, throat, or...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...